PlainRecalls
FDA Drug Moderate Class II Terminated

Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-533-05) bottles, Rx Only, Mfd. By. Dr. Reddy's Laboratories Limited, Bachupally 500 090 India

Reported: June 24, 2015 Initiated: May 22, 2015 #D-1135-2015

Product Description

Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-533-05) bottles, Rx Only, Mfd. By. Dr. Reddy's Laboratories Limited, Bachupally 500 090 India

Reason for Recall

Failed Dissolution Specifications; exceeded specification at the 9 hour time point

Details

Units Affected
100 count 7479; 500 count - 2544
Distribution
Nationwide
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 250 mg, 100 count (NDC 55111-533-01) and 500 count (NDC 55111-533-05) bottles, Rx Only, Mfd. By. Dr. Reddy's Laboratories Limited, Bachupally 500 090 India. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 100 count 7479; 500 count - 2544.
Why was this product recalled?
Failed Dissolution Specifications; exceeded specification at the 9 hour time point
Which agency issued this recall?
This recall was issued by the FDA Drug on June 24, 2015. Severity: Moderate. Recall number: D-1135-2015.